State of Alaska Department of Revenue lessened its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) by 1.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 35,017 shares of the company’s stock after selling 460 shares during the quarter. State of Alaska Department of Revenue’s holdings in Prestige Consumer Healthcare were worth $1,853,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. BNP Paribas Arbitrage SA lifted its position in Prestige Consumer Healthcare by 75.5% during the third quarter. BNP Paribas Arbitrage SA now owns 73,686 shares of the company’s stock valued at $4,135,000 after purchasing an additional 31,706 shares during the period. Bank of America Corp DE grew its holdings in shares of Prestige Consumer Healthcare by 6.5% in the fourth quarter. Bank of America Corp DE now owns 358,699 shares of the company’s stock worth $21,754,000 after acquiring an additional 21,826 shares during the period. Cubist Systematic Strategies LLC increased its position in Prestige Consumer Healthcare by 95.7% during the fourth quarter. Cubist Systematic Strategies LLC now owns 57,520 shares of the company’s stock valued at $3,489,000 after acquiring an additional 28,127 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in Prestige Consumer Healthcare during the fourth quarter valued at $8,111,000. Finally, CWM LLC purchased a new position in Prestige Consumer Healthcare in the fourth quarter worth about $1,930,000.
NYSE PBH opened at $59.58 on Friday. The company has a market capitalization of $2.99 billion, a PE ratio of 14.75, a price-to-earnings-growth ratio of 1.76 and a beta of 0.58. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.21 and a current ratio of 2.04. The business’s fifty day moving average is $55.72 and its 200 day moving average is $56.89. Prestige Consumer Healthcare Inc. has a fifty-two week low of $50.40 and a fifty-two week high of $63.83.
Prestige Consumer Healthcare (NYSE:PBH – Get Rating) last released its earnings results on Thursday, May 5th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.02. The company had revenue of $266.94 million for the quarter, compared to the consensus estimate of $258.25 million. Prestige Consumer Healthcare had a return on equity of 13.82% and a net margin of 18.90%. Prestige Consumer Healthcare’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.79 earnings per share. On average, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.19 EPS for the current year.
Several equities analysts have recently…